PUBLISHER: The Business Research Company | PRODUCT CODE: 1942472
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942472
Bone regeneration materials are bioactive substances and scaffolds created to repair or replace damaged bone by promoting cell growth and mineralization. These materials include grafts, biomimetic composites, and bioactive molecules that aim to replicate the structure and function of bone, addressing clinical needs such as defect size and healing speed.
The primary types of bone regeneration products include demineralized bone matrix (DBM), xenografts, autografts, synthetic bone grafts, bone morphogenetic protein (BMP), non-invasive electrical bone growth stimulators, and invasive electrical bone growth stimulators. Demineralized bone matrix is an allograft bone from which the mineral content has been removed, leaving behind collagen, proteins, and growth factors. These materials are made using various technologies such as 3D printing, electrospinning, sol-gel technology, and bioprinting. They are applied through surgical procedures, minimally invasive techniques, and other methods. Bone regeneration materials are used in spinal fusion, dental implants, joint reconstruction, craniomaxillofacial surgery, trauma repair, and more, and are utilized by hospitals, orthopedic clinics, dental clinics, research institutions, and other end users.
Tariffs are impacting the bone regeneration material market by increasing costs of imported biomaterials, ceramic composites, growth factors, and advanced manufacturing equipment used in graft and scaffold production. Hospitals and orthopedic clinics in North America and Europe are most affected due to reliance on imported regenerative materials, while Asia-Pacific faces higher production costs for export-focused manufacturers. These tariffs are increasing treatment costs and affecting procurement volumes. However, they are also encouraging domestic biomaterial innovation, regional production of bone graft substitutes, and stronger local supply chains for regenerative orthopedic solutions.
The bone regeneration material market research report is one of a series of new reports from The Business Research Company that provides bone regeneration material market statistics, including bone regeneration material industry global market size, regional shares, competitors with a bone regeneration material market share, detailed bone regeneration material market segments, market trends and opportunities, and any further data you may need to thrive in the bone regeneration material industry. This bone regeneration material market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bone regeneration material market size has grown strongly in recent years. It will grow from $4.1 billion in 2025 to $4.49 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising incidence of orthopedic injuries, increasing number of spinal fusion procedures, expansion of dental implant surgeries, advances in biomaterial science, growing adoption of bone graft substitutes.
The bone regeneration material market size is expected to see strong growth in the next few years. It will grow to $6.45 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for regenerative orthopedic solutions, rising use of personalized bone implants, expansion of bioprinting in orthopedics, growing focus on minimally invasive surgeries, increasing investments in advanced bone healing technologies. Major trends in the forecast period include increasing adoption of synthetic bone graft materials, rising use of 3D printed bone scaffolds, growing integration of growth factor-based therapies, expansion of minimally invasive bone repair techniques, enhanced focus on faster bone healing outcomes.
The rising prevalence of bone-related disorders is expected to drive the growth of the bone regeneration materials market in the coming years. Bone-related disorders include conditions affecting the bones, such as osteoporosis, osteoarthritis, and bone cancer, which can result in pain, fractures, and reduced mobility. Their increasing prevalence is largely due to an aging population, as older individuals are more prone to conditions like osteoporosis and osteoarthritis. Bone regeneration materials support the treatment of these disorders by promoting natural bone growth, restoring bone strength, and enhancing recovery in cases such as fractures and osteoporosis. For example, in July 2025, the Institute for Health Transformation, an Australia-based health research institute, reported that in 2023, a fracture occurred in Australia every 2.7 minutes, with projections indicating this rate will rise sharply to one fracture every 30 seconds by 2033. Consequently, the increasing prevalence of bone-related disorders is fueling the growth of the bone regeneration materials market.
Leading companies in the bone regeneration material market are focusing on developing innovative solutions such as synthetic bone graft substitutes to improve bone healing and regeneration. A synthetic bone graft substitute is an artificial material designed to replace or repair damaged bone tissue, promoting healing in medical procedures. For example, in May 2023, Royal Biologics, a U.S.-based medical device company, launched Bio-Reign 3D, an advanced bone graft substitute made from a hyper-crosslinked carbohydrate polymer. This material creates a highly porous 3D matrix to support bone regeneration, offering moldability, compressibility, and the ability to be sutured to prevent graft migration. Bio-Reign 3D is radiolucent upon implantation for clear imaging and turns radiopaque as new bone forms, allowing real-time monitoring of the healing process. Its biodegradation rate is aligned with natural bone formation, ensuring it is gradually replaced by healthy bone tissue.
In June 2023, Biocomposites, a UK-based medical device company, acquired Artoss GmbH to strengthen its bone regeneration portfolio. This acquisition enables Biocomposites to incorporate the proprietary NanoBone technology, enhancing its offerings to assist surgeons in treating patients with bone regeneration needs. Additionally, it expands the global reach of Artoss' innovative bone graft substitutes through Biocomposites' well-established distribution network. Artoss GmbH, based in Germany, specializes in manufacturing synthetic bone graft materials that aid in bone healing and growth.
Major companies operating in the bone regeneration material market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet, Smith & Nephew plc, Dentsply Sirona Inc., Straumann Holding AG, Integra LifeSciences Corporation, Osstem Implant, Exactech Inc., LifeNet Health, Orthofix Medical Inc., Biocomposites Ltd., NuVasive Inc., Xtant Medical Holdings Inc., Kuros Biosciences AG, LASAK s.r.o., NovaBone Products LLC, SigmaGraft, B&B Dental, Geistlich Pharma AG, RTI Surgical, Collagen Matrix Inc., DePuy Synthes, Wright Medical Group
North America was the largest region in the bone regeneration material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone regeneration material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bone regeneration material market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bone regeneration material market includes sales of bone grafts, barrier membranes, scaffolds, fixation devices, bone morphogenetic proteins, and stem cell-enriched matrices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bone Regeneration Material Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bone regeneration material market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bone regeneration material ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bone regeneration material market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.